Income Statement Balance Sheet Cash Flow Statement
Annual Financials for Raptor Pharmaceutical Corp.
Fiscal year is January-December. All values USD millions. 2009 2010 2011 2012 2013 5-year trend
Sales/Revenue 0 0 0 0 16.87M
Cost of Goods Sold (COGS) incl. D&A - - 231,092 - 1.65M
COGS excluding D&A - - 0 - 1.22M
Depreciation & Amortization Expense 223,192 224,491 231,092 211,000 437,000
Depreciation 84,693 72,241 77,592 65,000 244,000
Amortization of Intangibles 138,499 152,250 153,500 146,000 193,000
Gross Income - - (231,092) - 15.22M
2009 2010 2011 2012 2013 5-year trend
SG&A Expense 9.03M 12.83M 20.73M 35.96M 67.13M
Research & Development 6.57M 9.33M 14.79M 21.44M 29.18M
Other SG&A 2.46M 3.5M 5.95M 14.51M 37.95M
Other Operating Expense 0 0 0 0 0
Unusual Expense 0 5.89M 16.3M 3.18M 10.75M
EBIT after Unusual Expense 0 (5.89M) (16.3M) (3.18M) (10.75M)
Non Operating Income/Expense 0 (457) 29,319 360,000 (120,000)
Non-Operating Interest Income 36,744 25,701 44,836 340,000 188,000
Equity in Affiliates (Pretax) 0 0 0 0 0
Interest Expense 2,526 3,950 2,243 3,000 6.83M
Gross Interest Expense 2,526 3,950 2,243 3,000 6.83M
Interest Capitalized - - 0 0 0
Pretax Income (9.22M) (18.93M) (37.19M) (38.64M) (69.42M)
Income Tax 0 0 0 0 0
Income Tax - Current Domestic 0 0 0 - -
Income Tax - Current Foreign 0 0 0 - -
Income Tax - Deferred Domestic 0 0 0 - -
Income Tax - Deferred Foreign 0 0 0 - -
Income Tax Credits 0 0 0 - -
Equity in Affiliates 0 0 0 0 0
Other After Tax Income (Expense) 0 0 0 0 0
Consolidated Net Income (9.22M) (18.93M) (37.19M) (38.64M) (69.42M)
Minority Interest Expense 0 0 0 0 0
Net Income (9.22M) (18.93M) (37.19M) (38.64M) (69.42M)
Extraordinaries & Discontinued Operations 0 0 0 0 0
Extra Items & Gain/Loss Sale Of Assets 0 0 0 0 0
Cumulative Effect - Accounting Chg 0 0 0 0 0
Discontinued Operations 0 0 0 0 0
Net Income After Extraordinaries (9.22M) (18.93M) (37.19M) (38.64M) (69.42M)
Preferred Dividends 0 0 0 0 0
Net Income Available to Common (9.22M) (18.93M) (37.19M) (38.64M) (69.42M)
EPS (Basic) (10.88) (0.85) (1.15) (0.80) (1.20)
Basic Shares Outstanding 849,427 22.23M 32.33M 48.09M 57.86M
EPS (Diluted) (10.88) (0.85) (1.15) (0.80) (1.20)
Diluted Shares Outstanding 849,427 22.23M 32.33M 48.09M 57.86M
EBITDA (9.03M) (12.83M) (20.73M) (35.96M) (51.47M)
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.